- Q1 2024 Alimera Sciences Inc Earnings Call TranscriptMay 14, 2024€2.99 (-5.53%)Earnings
- Q4 2023 Alimera Sciences Inc Earnings Call TranscriptMar 07, 2024€3.51 (+1.74%)Earnings
- Q3 2023 Alimera Sciences Inc Earnings Call TranscriptOct 26, 2023€3 (+1.69%)Earnings
- Q2 2023 Alimera Sciences Inc Earnings Call TranscriptAug 10, 2023€2.97 (+7.22%)Earnings
- Q1 2023 Alimera Sciences Inc Earnings Call TranscriptMay 18, 2023€1.87 (+0.81%)Earnings
- Q4 2022 Alimera Sciences Inc Earnings Call TranscriptMar 31, 2023€1.91 (+12.50%)Earnings
- Q3 2022 Alimera Sciences Inc Earnings Call TranscriptNov 14, 2022€4.54 (-1.84%)Earnings
- Q2 2022 Alimera Sciences Inc Earnings Call TranscriptJul 27, 2022€5.25 (+3.35%)Earnings
- Q1 2022 Alimera Sciences Inc Earnings Call TranscriptMay 09, 2022€4.65 (-10.15%)Earnings
- Q4 2021 Alimera Sciences Inc Earnings Call TranscriptFeb 24, 2022€4.08 (+3.03%)Earnings
- Alimera Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 09, 2022
- Q3 2021 Alimera Sciences Inc Earnings Call TranscriptOct 28, 2021€3.76 (+1.08%)Earnings
- Q2 2021 Alimera Sciences Inc Earnings Call TranscriptAug 13, 2021€6.2 (-13.29%)Earnings
- Q1 2021 Alimera Sciences Inc Earnings Call TranscriptApr 29, 2021€8.3 (-9.78%)Earnings
- Q4 2020 Alimera Sciences Inc Earnings Call TranscriptFeb 25, 2021€6.55 (-5.76%)Earnings
- Q3 2020 Alimera Sciences Inc Earnings Call TranscriptOct 29, 2020€3.52 (-0.56%)Earnings
- Q2 2020 Alimera Sciences Inc Earnings Call TranscriptJul 30, 2020€4.92 (-0.81%)Earnings
- Alimera Sciences Inc to Discuss NEW DAY Clinical Trial Conference Call TranscriptJul 15, 2020
- Alimera Sciences Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- Q1 2020 Alimera Sciences Inc Earnings Call TranscriptApr 30, 2020€5.5 (+14.58%)Earnings
- Q4 2019 Alimera Sciences Inc Earnings Call TranscriptFeb 27, 2020€6.42 (+8.81%)Earnings
- Alimera Sciences Inc Extraordinary Shareholders Meeting TranscriptNov 04, 2019
- Q3 2019 Alimera Sciences Inc Earnings Call TranscriptOct 30, 2019€4.01 (-4.07%)Earnings
- Q2 2019 Alimera Sciences Inc Earnings Call TranscriptJul 30, 2019€8.47 (-31.19%)Earnings
- Alimera Sciences Inc Annual Shareholders Meeting TranscriptJun 18, 2019
- Q1 2019 Alimera Sciences Inc Earnings Call TranscriptApr 30, 2019€12.71 (-0.63%)Earnings
- Q4 2018 Alimera Sciences Inc Earnings Call TranscriptFeb 19, 2019€14.01 (-4.17%)Earnings
Alimera Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Good day, and welcome to the Second Annual Winter Wonderland Best Ideas Conference. The next presenting company is Alimera Sciences. (Operator Instructions)
I'd now like to turn the floor over to today's host, Rick Eiswirth, President and CEO of Alimera Sciences. Sir, the floor is yours.
Great. Thank you very much, and thank you all for joining me today. As our opening slide sits here today, the focus for Alimera is retina disease. We think there's a unique opportunity here to build a special company based on built around retina specialists and their patients. I think there's unique opportunity there because, frankly, no one else is doing it. There's only about 10 or 11 products that have ever been approved for the retina. And most of those products are a single product in a much bigger company that is focused outside the eye. And so that retina specialist doesn't get the focus of the company.
To give you an example, sort of the standard of care in retina disease is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)